欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0923/002
药品名称
GLIMEPIRIDE SANDOZ GMBH
活性成分
glimepiride 2.0 mg
剂型
Tablet
上市许可持有人
Sandoz GmbH Biochemiestraße 10 Kundl Tirol - 6250 Austria
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Denmark (DK)
Glimeprisan
许可日期
2008/06/12
最近更新日期
2023/10/11
药物ATC编码
A10BB12 glimepiride
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PAR
|
parmod5_dk1163glimeprisan_pdf
Date of last change:2022/06/02
Final SPC
|
Common_spc DK_H_1163_001_004_IB_023 _ clean
Date of last change:2020/10/01
Final Labelling
|
1_3_1 spc_label_pl _ common_outer _ 5_361 _ clean
Date of last change:2020/01/11
Final PL
|
1_3_1 spc_label_pl _ common_pl _ 11_241 _ clean
Date of last change:2020/01/11
Final Product Information
|
1_3_1_spc_label_pl___common_pl_ 1163 _ clean
Date of last change:2018/11/09
Final Product Information
|
1_3_1 spc_label_pl _ common_spc _ 1163 _clean
Date of last change:2018/11/09
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase